Show simple item record

dc.contributor.advisorLovett, Anneha
dc.contributor.authorNobles, Brittney
dc.date.accessioned2013-04-23T15:46:00Z
dc.date.available2013-04-23T15:46:00Z
dc.date.issued2013-04-23
dc.identifier.urihttp://hdl.handle.net/10898/1506
dc.descriptionSwilley Library Award of Merit for Excellence in Academic Researchen_US
dc.description.abstractPurpose: To provide a comprehensive source document on previously published cost-saving data on the FDA approved Alzheimer’s medications in the United States. This study reviews published pharmacoeconomic analyses of FDA approved drugs classes for Alzheimer’s disease management.en_US
dc.language.isoen_USen_US
dc.subjectAlzheiber's Disease
dc.subjectEconomic Outcomes
dc.titleAlzheimer’s Disease: A Summary of Economic Outcomesen_US
dc.typeArticleen_US
refterms.dateFOA2020-09-29T13:42:39Z


Files in this item

Thumbnail
Name:
Alzheimer's Disease A Summary ...
Size:
223.5Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record